BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16410353)

  • 1. Molecular basis for substrate recognition by MTMR2, a myotubularin family phosphoinositide phosphatase.
    Begley MJ; Taylor GS; Brock MA; Ghosh P; Woods VL; Dixon JE
    Proc Natl Acad Sci U S A; 2006 Jan; 103(4):927-32. PubMed ID: 16410353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structure and regulation of myotubularin phosphatases.
    Begley MJ; Dixon JE
    Curr Opin Struct Biol; 2005 Dec; 15(6):614-20. PubMed ID: 16289848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of a phosphoinositide phosphatase, MTMR2: insights into myotubular myopathy and Charcot-Marie-Tooth syndrome.
    Begley MJ; Taylor GS; Kim SA; Veine DM; Dixon JE; Stuckey JA
    Mol Cell; 2003 Dec; 12(6):1391-402. PubMed ID: 14690594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myotubularins, a large disease-associated family of cooperating catalytically active and inactive phosphoinositides phosphatases.
    Laporte J; Bedez F; Bolino A; Mandel JL
    Hum Mol Genet; 2003 Oct; 12 Spec No 2():R285-92. PubMed ID: 12925573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane association of myotubularin-related protein 2 is mediated by a pleckstrin homology-GRAM domain and a coiled-coil dimerization module.
    Berger P; Schaffitzel C; Berger I; Ban N; Suter U
    Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12177-82. PubMed ID: 14530412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of the dual specificity protein phosphatase VHR.
    Yuvaniyama J; Denu JM; Dixon JE; Saper MA
    Science; 1996 May; 272(5266):1328-31. PubMed ID: 8650541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of phosphoinositide binding domain properties within the myotubularin-related protein MTMR3.
    Lorenzo O; Urbé S; Clague MJ
    J Cell Sci; 2005 May; 118(Pt 9):2005-12. PubMed ID: 15840652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of myotubularin-related (MTMR)2 phosphatidylinositol phosphatase by MTMR5, a catalytically inactive phosphatase.
    Kim SA; Vacratsis PO; Firestein R; Cleary ML; Dixon JE
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4492-7. PubMed ID: 12668758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of phosphatase activity in myotubularin-related protein 2 is associated with Charcot-Marie-Tooth disease type 4B1.
    Berger P; Bonneick S; Willi S; Wymann M; Suter U
    Hum Mol Genet; 2002 Jun; 11(13):1569-79. PubMed ID: 12045210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The myotubularin family: from genetic disease to phosphoinositide metabolism.
    Laporte J; Blondeau F; Buj-Bello A; Mandel JL
    Trends Genet; 2001 Apr; 17(4):221-8. PubMed ID: 11275328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The myotubularin family: novel phosphoinositide regulators.
    Nandurkar HH; Huysmans R
    IUBMB Life; 2002 Jan; 53(1):37-43. PubMed ID: 12018406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metastasis-promoting phosphatase PRL-3 shows activity toward phosphoinositides.
    McParland V; Varsano G; Li X; Thornton J; Baby J; Aravind A; Meyer C; Pavic K; Rios P; Köhn M
    Biochemistry; 2011 Sep; 50(35):7579-90. PubMed ID: 21806020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structure of phosphoinositide phosphatases: Insights into substrate specificity and catalysis.
    Hsu F; Mao Y
    Biochim Biophys Acta; 2015 Jun; 1851(6):698-710. PubMed ID: 25264170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B.
    Salmeen A; Andersen JN; Myers MP; Tonks NK; Barford D
    Mol Cell; 2000 Dec; 6(6):1401-12. PubMed ID: 11163213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for phosphoinositide substrate recognition, catalysis, and membrane interactions in human inositol polyphosphate 5-phosphatases.
    Trésaugues L; Silvander C; Flodin S; Welin M; Nyman T; Gräslund S; Hammarström M; Berglund H; Nordlund P
    Structure; 2014 May; 22(5):744-55. PubMed ID: 24704254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. I-proteins - a proposed switch in myotubularin function.
    Clague MJ; Dove SK; Barr FA
    Trends Biochem Sci; 2004 Feb; 29(2):58-61. PubMed ID: 15102431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myotubularin phosphoinositide phosphatases in human diseases.
    Amoasii L; Hnia K; Laporte J
    Curr Top Microbiol Immunol; 2012; 362():209-33. PubMed ID: 23086420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of the catalytic domain of protein-tyrosine phosphatase SHP-1.
    Yang J; Liang X; Niu T; Meng W; Zhao Z; Zhou GW
    J Biol Chem; 1998 Oct; 273(43):28199-207. PubMed ID: 9774441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational and structure-guided design of phosphoinositide substrate specificity into the tyrosine specific LMW-PTP enzyme.
    Egbe E; Levy CW; Tabernero L
    PLoS One; 2020; 15(6):e0235133. PubMed ID: 32584877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phosphoinositide-3-phosphatase MTMR2 associates with MTMR13, a membrane-associated pseudophosphatase also mutated in type 4B Charcot-Marie-Tooth disease.
    Robinson FL; Dixon JE
    J Biol Chem; 2005 Sep; 280(36):31699-707. PubMed ID: 15998640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.